🔍
Search Results - colin+shea
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
SuBLIME: Automatic Brain Lesion Incidence and Detection Using Multimodality Longitudinal Magnetic Resonance Imaging
Subjects develop brain lesions over the natural course of a disease, Thus, there is a need to identify, estimate the size, and track the time course of new lesions as they are being formed and remain in the brain. Currently, this is done by a trained rteuroradiologist using sliceby- slice inspection, this process is very slow, can be prone to human...
Published: 3/13/2025
|
Inventor(s):
Elizabeth Sweeney
,
Colin Shea
,
Russell Shinohara
,
Arthur Goldsmith
,
Daniel Reich
,
Ciprian Crainiceanu
Keywords(s):
Brain Cancer
,
Cancers
,
CNS and Neurological Disorders
,
Disease Indication
,
Image Display Software
,
Image Processing Software
,
Imaging and Sensing Systems
,
Imaging Modality
,
In Vivo Medical Imaging
,
Magnetic Resonance Imaging (MRI)
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Neurology
,
Technology Classifications > Computers, Electronics & Software
,
Technology Classifications > Medical Devices > Imaging
,
Technology Classifications > Medical Devices
,
Technology Classifications > Computers, Electronics & Software > Image Processing & Analysis
,
Clinical and Disease Specializations > Oncology > Brain Cancer
A p105-based NF-(kappa) B Super repressor
C04290: A p105-based NF-(kappa) B Super repressor Technical Details: Nuclear factor (NF)-kB is a family of transcription factors that regulate immune and inflammatory responses, programmed cell death (apoptosis), and developmental processes. In normal cells, NF-kB is latent, and is activated transiently by stimuli and stresses. However, under pathological...
Published: 3/13/2025
|
Inventor(s):
Li Lin
Keywords(s):
Biologics
,
Cancers
,
Chemotherapy
,
Disease Indication
,
Nucleic Acid
,
Single
,
Skin Cancer
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Dermatology
,
Clinical and Disease Specializations > Oncology > Skin Cancer
,
Technology Classifications > Therapeutic Modalities > Gene Therapies
,
Technology Classifications > Therapeutic Modalities > Proteins
,
Technology Classifications > Therapeutic Modalities > Targets
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum